Sonnet Biotherapeutics Holdings IncSonnet Biotherapeutics Holdings Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Jump to the bottom of this page for potential risks for Sonnet Biotherapeutics Holdings Inc based on industry, geography and size. If you are employed by Sonnet Biotherapeutics Holdings Inc and you would like to use your Sustainability aseessment, please get in touch. This webpage displays a zero-cost Sustainability analysis for Sonnet Biotherapeutics Holdings Inc.

Sonnet Biotherapeutics Holdings Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.6; made up of an environmental score of 2.7, social score of 6.0 and governance score of 8.0.

SDG Transparency Score for Sonnet Biotherapeutics Holdings Inc 
Low
0 - 3

5.6

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Sonnet Biotherapeutics Holdings Inc 
2.7

Environmental

6.0

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
774Virpax Pharmaceuticals Inc
5.7
High
774Zymeworks Inc
5.7
High
808Sonnet Biotherapeutics Holdings Inc
5.6
High
808Armata Pharmaceuticals Inc
5.6
High
808Biostage Inc
5.6
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Sonnet Biotherapeutics Holdings Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc offer flexible work?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc disclose water use targets?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Sonnet Biotherapeutics Holdings Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Sonnet Biotherapeutics Holdings Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Sonnet Biotherapeutics Holdings Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc disclose its waste policy?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc disclose energy use targets?

LockedSign up for free to unlock

Does Sonnet Biotherapeutics Holdings Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Sonnet Biotherapeutics Holdings Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Sonnet Biotherapeutics Holdings Inc
These potential risks are based on the size, segment and geographies of the company.

Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy. It has a license agreement with New Life Therapeutics PTE, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin 6. Sonnet BioTherapeutics Holdings, Inc. is based in Princeton, New Jersey.

Sorry!

Failed to process!